Mezavant 1.2 g

Mezavant 1.2 G is a delayed and extended-release tablet containing mesalazine, used for managing inflammatory bowel conditions. This medication is designed to deliver consistent relief over an extended period.

Mezavant 1.2 G is primarily used for the treatment of inflammatory bowel conditions, such as ulcerative colitis. It helps to reduce inflammation in the colon and rectum, providing relief from symptoms like abdominal pain and diarrhea. Mesalazine, the active ingredient, is often recommended for maintaining remission in these conditions.

Common effects of Mezavant 1.2 G may include mild gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience headaches or dizziness. These effects are generally temporary and should subside as the body adjusts to the medication.

Mezavant 1.2 G should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and not to crush or chew the tablets, as this can affect the extended-release mechanism. Patients with known allergies to mesalazine or sulfasalazine should avoid this medication.

Mezavant 1.2 G may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other bowel preparations. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.